← Back to all events
MINTNew ScientistJun 23, 2026

Unapproved gene therapy for boosting longevity is set to go on sale

View original article →
Final score
-5.51
Confidence
9/10
Amount
5M CBWD

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=MINT -> MINT (human chose this in 87% of 272 past reviews)] Both analysts agree on MINT; unapproved therapy bypasses safety regulations, violating health rights. | The action enables unregulated medical interventions with significant potential for harm, violating fundamental rights to health, safety, and informed consent. While the stated goal (longevity enhancement) may align with SDG 3, the bypassing of regulatory oversight creates sy